Pancreatic Cancer Research

ResearcherCasa Sollievo della SofferenzaActive in the last 2 years

Andrea Fontana

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6660-5315; OpenAlex author ID A5069861798. Sources: OpenAlex.

Their work

Papers
12 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: 2 papers · 2015: 1 paper · 2016: 2 papers · 2017: none · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 12

  1. A powerful machine learning approach to identify interactions of differentially abundant gut microbial subsets in patients with metastatic and non-metastatic p… First author DOI 10.1080/19490976.2024.2375483↗
  2. Evaluation of inherited germline mutations in cancer susceptibility genes among pancreatic cancer patients: a single-center study. Co-author DOI 10.1186/s10020-023-00600-1↗
  3. Clinical Significance of Circulating miR-1273g-3p and miR-122-5p in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2020.00044↗
  4. Early-Onset Diabetes as Risk Factor for Pancreatic Cancer: miRNA Expression Profiling in Plasma Uncovers a Role for miR-20b-5p, miR-29a, and miR-18a-5p in Diab… First author DOI 10.3389/fonc.2020.01567↗
  5. Influence of gemcitabine chemotherapy on the microbiota of pancreatic cancer xenografted mice. Co-author DOI 10.1007/s00280-018-3549-0↗
  6. Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites. Co-author DOI 10.18632/oncotarget.6808↗
  7. Development of a metabolites risk score for one-year mortality risk prediction in pancreatic adenocarcinoma patients. Co-author DOI 10.18632/oncotarget.7108↗
  8. SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: Effect of starvation. Co-author DOI 10.3109/07420528.2014.1003351↗
  9. A tumour score with multidetector spiral CT for venous infiltration in pancreatic cancer: influence on borderline resectable. Co-author DOI 10.1007/s11547-013-0349-9↗
  10. Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clini… First author DOI 10.1186/s12967-014-0248-4↗
  11. Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival. Co-author DOI 10.1016/j.ajpath.2012.07.016↗
  12. Time-Qualified Patterns of Variation of PPARγ, DNMT1, and DNMT3B Expression in Pancreatic Cancer Cell Lines. Co-author DOI 10.1155/2012/890875↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Francesca Tavano · 9 shared papers, 2012–2023 · strength 0.62
  2. Angelo Andriulli · 8 shared papers, 2012–2020 · strength 0.52
  3. Evaristo Maiello · 4 shared papers, 2014–2024 · strength 0.49
  4. Valerio Pazienza · 7 shared papers, 2012–2024 · strength 0.47
  5. Francesco Perri · 2 shared papers, 2023–2024 · strength 0.35
  6. Tiziana Pia Latiano · 2 shared papers, 2023–2024 · strength 0.35
  7. Tommaso Mazza · 4 shared papers, 2016–2020 · strength 0.34
  8. Concetta Panebianco · 3 shared papers, 2015–2024 · strength 0.30
  9. Annacandida Villani · 1 shared paper, 2024 · strength 0.18
  10. Fabio F. di Mola · 5 shared papers, 2012–2015 · strength 0.17
  11. Pierluigi Di Sebastiano · 5 shared papers, 2012–2015 · strength 0.17
  12. Iole Maria Di Gangi · 2 shared papers, 2016 · strength 0.11
  13. Kaarel Adamberg · 1 shared paper, 2018 · strength 0.08
  14. Lucia Lombardi · 2 shared papers, 2014–2015 · strength 0.08
  15. Gianluigi Mazzoccoli · 2 shared papers, 2012–2015 · strength 0.07
  16. Francesco Giuliani · 1 shared paper, 2015 · strength 0.04
  17. Tiziana Marinelli · 1 shared paper, 2014 · strength 0.04
  18. Markus Wolfgang Büchler · 1 shared paper, 2014 · strength 0.04
  19. Vincenzo Corbo · 1 shared paper, 2012 · strength 0.03
  20. Alessandra Rosati · 1 shared paper, 2012 · strength 0.02
  21. Elisa Dalla Pozza · 1 shared paper, 2012 · strength 0.02
  22. Marta Palmieri · 1 shared paper, 2012 · strength 0.02
  23. Raffaéle Palaia · 1 shared paper, 2012 · strength 0.02
  24. Ilaria Dando · 1 shared paper, 2012 · strength 0.02
  25. Vincenzo De Laurenzi · 1 shared paper, 2012 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.